Search


Current filters:





Start a new search
Add filters:

Use filters to refine the search results.


Results 1-4 of 4 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
1-Feb-2011Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected thai patients receiving indinavir boosted with ritonavirTim R. Cressey; Saik Urien; Deborah Hirt; Guttiga Halue; Malee Techapornroong; Chureeratana Bowonwatanuwong; Prattana Leenasirimakul; Jean Marc Treluyer; Gonzague Jourdain; Marc Lallemant
1-Jan-2016A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based RegimensNontiya Homkham; Tim R. Cressey; Lily Ingsrisawang; Naïm Bouazza; Chaiwat Ngampiyaskul; Suchat Hongsiriwon; Sakulrat Srirojana; Suparat Kanjanavanit; Sorakij Bhakeecheep; Sophie Le Coeur; Nicolas Salvadori; Jean Marc Treluyer; Gonzague Jourdain; Saik Urien
1-Jan-2015Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancyTim R. Cressey; Saik Urien; Edmund V. Capparelli; Brookie M. Best; Sudanee Buranabanjasatean; Aram Limtrakul; Boonsong Rawangban; Prapan Sabsanong; Jean Marc Treluyer; Gonzague Jourdain; Alice Stek; Marc Lallemant; Mark Mirochnick
1-Jan-2017Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patientsNaïm Bouazza; Tim R. Cressey; Frantz Foissac; Andrzej Bienczak; Paolo Denti; Helen McIlleron; David Burger; Martina Penazzato; Marc Lallemant; Edmund V. Capparelli; Jean Marc Treluyer; Saïk Urien